ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients

Patients with advanced stage non-small cell lung carcinoma (NSCLC) harboring an anaplastic lymphoma kinase ALK gene rearrangement, detected from a tissue sample, can benefit from targeted ALK inhibitor treatment. However, while treatment is initially effective in most cases, relapse or progression o...

Full description

Bibliographic Details
Main Author: Paul Hofman
Format: Article
Language:English
Published: MDPI AG 2017-08-01
Series:Cancers
Subjects:
ALK
Online Access:https://www.mdpi.com/2072-6694/9/8/106